<DOC>
	<DOCNO>NCT00540735</DOCNO>
	<brief_summary>Unresectable type III IV cholangiocarcinoma bad prognosis ; survival median range 6 9 month . Survival depend biliary drainage quality , obtain plastic metallic prothesis set one several hepatic segment . Radiotherapy and/or chemotherapy n't prove yet efficiency survival . In France , gemcitabin recommend French Digestive Oncology Federation metastatic tumour , monotherapy associate cisplatin oxaliplatin ( Gemox ) patient good general condition . Photodynamic therapy show 3 prospective study - one randomize - small patient series , significative efficiency survival quality life treat patient , comparison historical series , patient ' group whose biliary drainage case unefficient . A new randomize study , include patient whose biliary drainage efficient compare become treat PDT addition current practice , current practice , seem justified . The principal objective study evaluate efficiency PDT Photofrin® patient unresectable type III IV cholangiocarcinoma .</brief_summary>
	<brief_title>Efficiency Evaluation Photodynamic Therapy With Photofrin® Unresectable Type III IV Cholangiocarcinomas</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<mesh_term>Hematoporphyrin Derivative</mesh_term>
	<mesh_term>Trioxsalen</mesh_term>
	<criteria>Obtention write informed consent . Patient 18 . Patient type III IV ( accord Bismuth classification ) histologically prove cholangiocarcinoma ; histologic diagnosis must prove biliary brushing , bile cytology , endobiliary biopsy scope control pediatric plier , cytologic puncture scan echoendscopic control . Patient Karnofsky score ≥ 50 % Patient efficient initial biliary drainage prothesis . Cancer classify maximum T3N1M1 , intrahepatic metastasis occupy less 25 % hepatic parenchyme ( accord TNM cancer classification extrahepatic biliary duct ' cancer ) . Patient capable fill quality life questionnaire . No write informed consent . Type I II cholangiocarcinoma accord Bismuth classification . Patients ASA score 4 . Patients clinical biological sign biliary infection . Patients severe visceral disease cholangiocarcinoma . Patients without efficient initial biliary drainage . Patients extrahepatic visceral metastasis , except perihilar ganglionic metastasis classify T4N1M+ accord TNM classification . Patients whose cholangiocarcinoma already resect . Patients already treat radiotherapy chemotherapy treatment cholangiocarcinoma . Patients first treat metallic prothesis . Patients contraindication MRI . Patients porphyria hypersensibility porphyrin . Patient treat non authorize treatment time inclusion . Pregnant , parturient breastfeed woman . Non menopaused woman without efficient contraception . Patient 18 . Person 18 protection accord French Public Health Code . Person affiliate social security regimen , benefit regimen . Person exclusion period another biomedical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>